Table 1.
Patient and tumor characteristics
| Characteristics | No fiducial (n = 46) | Fiducial (n = 50) |
|---|---|---|
| Age Median (range) | 68 (42.0-81.9) | 72.4 (37.0-87.0) |
| Sex | ||
| Female | 24 (52.2) | 18 (36.0) |
| Male | 22 (47.8) | 32 (64.0) |
| Baseline ECOG performance status | ||
| 0 | 18 (39.1) | 9 (18.0) |
| 1 | 23 (50.0) | 36 (72.0) |
| 2 | 4 (8.7) | 5 (10.0) |
| 3 | 1 (2.2) | 0 (0.0) |
| Pancreatic cancer stage | ||
| Resectable | 11 (23.9) | 7 (14.0) |
| Borderline resectable | 21 (45.7) | 20 (40.0) |
| Locally advanced | 14 (30.4) | 23 (46.0) |
| Tumor location | ||
| Head of the pancreas | 34 (73.9) | 30 (60.0) |
| Body of the pancreas | 8 (17.4) | 12 (24.0) |
| Tail of the pancreas | 1 (2.2) | 0 (0.0) |
| Pancreatic duct | 0 (0.0) | 2 (4.0) |
| Uncinate process | 1 (2.2) | 0 (0.0) |
| Other | 2 (4.3) | 6 (12.0) |
Abbreviation: ECOG = Eastern Cooperative Oncology Group.